Do you deal with drug pricing and reimbursement in North America or work in health economics or outcomes research? Do you want to hear about the latest trends in P&R and what the future holds?
SAE Media Group’s 4th Annual conference on Pharmaceutical Pricing and Reimbursement in North America will arm you with all the tools and up-to-date knowledge you need to successfully manage this. This conference will bring together top pharmaceutical companies and government agencies discussing significant changes in pricing and reimbursement controls, and their visions for future developments.
Key benefits of attending:
- Discover the latest updates on Medicare and Medicaid; and how the rest of North America is shaping up
- Acquire knowledge on the best practises to optimise pricing within your business to ensure you remain profitable
- Assess how health economics and outcomes research can be used to forecast future pricing trends
- Gain an insight into the views of payers, patients and insurance companies
- Examine how the general elections will affect pricing
Hear contributions from leading experts such as:
- Celestina Arrigo, Director, Global Health Outcomes, UCB Pharma SA
- Donald Zowader, Manager, Government Affairs, Takeda Pharmaceuticals
- W. Neil Palmer, Vice President, RTI Health Solutions
- Jorge Mestre-Ferrandiz, Senior Economist, Office of Health Economics
- Sarah Pitluck, Principal Analyst, Genentech
- Veronique Toully, Director, Global Pricing Reimbursement and Access, UCB Group
- Philip Jacobs, Director, Health Economics, Institute of Health Economics
- Arto Ohinmaa, Professor, School of Public Health, University of Alberta
- Leah Amir, Executive Director and President of VantageView, Institute for Quality Resource Management
- Gary Johnson, Managing Director, Inpharmation
- Pamela Santoni, Senior Principal, IMS Health
George Wyatt, Managing Director, Wyatt Health Management
Gustav Ando, Project Manager, Global Insight
David W. Miller, Former Vice President and Site Head, Elan Pharma Ltd. and President, Miller Pharma Consulting
- Brian Lovatt, Managing Director & Chief Executive, Vision Healthcare Research
This conference is aimed at:
A Vice President, Director or Manager from:
- Pricing
- Reimbursement & Access
- Business development
- Strategy analysts
- Purchasing
| - Economic affairs
- Health economics
- Outcomes research
- Pharmaceutical policy
- Corporate / Regulatory / Government affairs
|
As well as experts from the following institutions:
- Health Care
- Hospitals / Pharmacies
| - Pricing/ Strategic Consultancies
- Academia
|
Last years’ delegates included:
- Pfizer
- AstraZeneca Pharmaceuticals
- Novartis
- GlaxoSAE Media GroupthKline
- Roche
| - UCB Group
- Takeda Pharmaceuticals
- Merck Lipha S A
- Bioniche Life Sciences Inc.
- Santhera Pharmaceuticals AG
|
For Sponsorship opportunities please contact Alia Malick at